Home
Conditions
Blood-Borne Infections

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,274 public trials 442 recruiting studies

Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)

NCT01025596

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +13 more
Locations: Hopital Jean Verdier Bondy, France

Beaujon Hospital Clichy, France

Hopital Kremlin Bicêtre Le Kremlin-Bicêtre, France

Hopital Civil Strasbourg, France

View Trial Details

Completed

Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral Density

NCT01153217

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Bone Diseases, +20 more
Locations: Lluita contra la SIDA Foundation Badalona, Barcelona, Spain

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

View Trial Details

Completed

Keyhole Limpet Hemocyanin in Chronic Hepatitis C

NCT01509391

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Medical University of Graz Graz, Austria

View Trial Details

Completed

VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir

NCT01253551

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

NCT01467531

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations: GSK Investigational Site Buffalo, New York, United States

View Trial Details

Completed

Evaluation of the Bioequivalence of a Combined Formulated Tablet

NCT01622790

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Overland Park, Kansas, United States

View Trial Details

Completed

TMC435-TiDP16-C116 - Relative Bioavailability and Food Effect Study

NCT01308606

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r)

NCT01323257

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Antwerp, Belgium

View Trial Details

Completed

Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women

NCT00745368

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Completed

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

NCT01026610

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Queen Mary Hospital Hong Kong, China

Hanyang University Guri Hospital Guri-si, Gyeonggi-do, South Korea

Inha University Hospital Incheon, Inchen, South Korea

Kyungpook National University Hospital Daegu, South Korea

View Trial Details

Blood-Borne Infections

Blood-Borne Infections trial results

Related conditions